High glucose alters cardiomyocyte contacts and inhibits myofibrillar formation

被引:45
作者
Dyntar, D
Sergeev, P
Klisic, J
Ambühl, P
Schaub, MC
Donath, MY
机构
[1] Univ Hosp Zurich, Div Endocrinol & Diabet, CH-8091 Zurich, Switzerland
[2] Univ Hosp Zurich, Div Nephrol, CH-8091 Zurich, Switzerland
[3] Univ Zurich, Inst Pharmacol & Toxicol, CH-8032 Zurich, Switzerland
关键词
D O I
10.1210/jc.2005-1904
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: The frequency of diabetes-related heart failure along with the prevalence of diabetes is increasing. Diabetic cardiomyopathy is considered to be a distinct disease in the absence of discernible coronary artery and other defined heart disease. Previously we have shown that glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in cultivated cardiomyocytes. Objective: Here we studied the mechanisms of diabetic cardiomyopathy in more detail. Results: Streptozotocin-induced diabetes led to a significant increase in cardiac cell apoptosis. Furthermore, cardiomyocyte contacts were reduced. In vitro, prolonged exposure of cultured adult cardiomyocytes to high glucose concentrations drastically reduced myofibrillar formation. In particular, sarcomeric myosin heavy chains and cardiac alpha-actin were reduced, whereas the nonsarcomeric smooth muscle alpha-actin remained unaffected. The deleterious effects of glucose on myofibril formation were prevented by antioxidative regimens. Conclusions: Thus, a diabetic milieu leads to multiple structural alterations of the heart including apoptosis, loss of intercellular contacts, and malformation of contractile structures.
引用
收藏
页码:1961 / 1967
页数:7
相关论文
共 37 条
[1]   Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: A short review [J].
Adeghate, E .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 261 (1-2) :187-191
[2]   Roles of cardiac transcription factors in cardiac hypertrophy [J].
Akazawa, H ;
Komuro, I .
CIRCULATION RESEARCH, 2003, 92 (10) :1079-1088
[3]   Myocyte renewal and ventricular remodelling [J].
Anversa, P ;
Nadal-Ginard, B .
NATURE, 2002, 415 (6868) :240-243
[4]   Diabetes and idiopathic cardiomyopathy - A nationwide case-control study [J].
Bertoni, AG ;
Tsai, A ;
Kasper, EK ;
Brancati, FL .
DIABETES CARE, 2003, 26 (10) :2791-2795
[5]   Differential activation of mitogen-activated protein kinases in ischemic and anesthetic preconditioning [J].
da Silva, R ;
Grampp, T ;
Pasch, T ;
Schaub, MC ;
Zaugg, M .
ANESTHESIOLOGY, 2004, 100 (01) :59-69
[6]   Calibrated histochemistry applied to oxygen supply and demand in hypertrophied rat myocardium [J].
Des Tombe, AL ;
Van Beek-Harmsen, BJ ;
Lee-De Groot, MBE ;
Van Der Laarse, WJ .
MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 58 (05) :412-420
[7]  
deVries JE, 1997, J LIPID RES, V38, P1384
[8]   Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes [J].
Donath, MY ;
Gross, DJ ;
Cerasi, E ;
Kaiser, N .
DIABETES, 1999, 48 (04) :738-744
[9]   Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications [J].
Donath, MY ;
Halban, PA .
DIABETOLOGIA, 2004, 47 (03) :581-589
[10]   INSULIN-LIKE GROWTH-FACTOR-I STIMULATES MYOFIBRIL DEVELOPMENT AND DECREASES SMOOTH-MUSCLE ALPHA-ACTIN OF ADULT CARDIOMYOCYTES [J].
DONATH, MY ;
ZAPF, J ;
EPPENBERGEREBERHARDT, M ;
FROESCH, ER ;
EPPENBERGER, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (05) :1686-1690